Search
for

    Sort by

    Research 391–420 of 1000+

    1. Risk factors for prostate cancer: a case-control study in Greece International Journal of Cancer · 1999 · 127 citations
    2. Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer Anti-cancer drugs · 2000 · 81 citations
    3. Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity Anti-Cancer Agents in Medicinal Chemistry · 2009 · 73 citations
    4. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. PubMed · 2002 · 21 citations
    5. The influence of <i>Castanea sativa</i> Mill. flower extract on hormonally and chemically induced prostate cancer in a rat model Food & Function · 2021 · 7 citations
    6. Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia The Journal of Urology · 2017 · 1 citations
    7. Review of hair prosthetic options for patients with alopecia Journal of cosmetic dermatology · 2023
    8. Evaluation of the CNC® prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study BMC women's health · 2022
    9. Fluxactive Complete (#1 PREMIUM PROSTATE SUPPORT FORMULA) Managing Prostate Wellness And Bladder Functions! Zenodo (CERN European Organization for Nuclear Research) · 2022
    10. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study UNC Libraries · 2020
    11. Photoacoustic imaging for prostate brachytherapy cIRcle (University of British Columbia) · 2014
    12. Management of Advanced Prostate Cancer Undergoing Major Shift Oncology times · 2011
    13. Urological Oncology: Prostate Cancer 2010
    14. How not to detect prostate cancer Lancet Oncology · 2007
    15. Effects of the androgen receptor overexpression in prostate cancer 2007
    16. TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine Clinical Cancer Research · 2006
    17. Doxetaxel: new indication. Prostate cancer: a few more weeks. PubMed · 2006
    18. Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms Central European Journal of Urology · 2019
    19. Androgen biosynthetic pathways in the human prostate 2008 · 160 citations
    20. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients The American Journal of Medicine · 1992 · 116 citations
    21. New Methods of Endocrine Management of Prostatic Cancer 1987 · 67 citations
    22. Five-alpha-reductase Inhibitors for prostate cancer prevention. The Cochrane library · 2008 · 37 citations
    23. Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis Journal of The American Academy of Dermatology · 2013 · 34 citations
    24. Estimating the Contribution of the Prostate to Blood Dihydrotestosterone 2003 · 28 citations
    25. Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents. Revista chilena de nutrición · 2017 · 3 citations
    26. Evaluation of Sex Hormone Levels in Benign Prostatic Hyperplasia Patients Treated with 5 Alpha-Reductase Inhibitor (Finasteride) in Amara city/Iraq Baghdad Science Journal · 2020 · 2 citations
    27. Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality The International Journal of Medical Science and Health Research · 2024 · 1 citations
    28. Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta. PubMed · 2026
    29. 5-alpha reductase inhibitors use in prostatic disease and beyond Translational Andrology and Urology · 2023
    30. Medico-Surgical Therapeutic Management of Benign Prostatic Hyperplasia Global Journal of Reproductive Medicine · 2023